Results 81 to 90 of about 6,856 (183)

Synthesis, characterization, in silico and in vitro studies of novel glycoconjugates as potential antibacterial, antifungal, and antileishmanial agents

open access: yesOpen Chemistry
In the present work, several new glycoconjugates (8a–e) were generated from glycopyranosyl-α-trichloroacetimidates (sugar-OTCA) as glycosyl donors and dimethyl-l-tartrate as an aglycone acceptor in good to excellent yields.
Khan Sher Wali   +11 more
doaj   +1 more source

Biological Evaluation of 3-Aryl and/or 4-(N-Aryl)aminocoumarins Against Human Pathogens: Antileishmanial and Antiviral Activities

open access: yesFuture Pharmacology
Background: Vector-borne diseases, such as leishmaniasis and arboviral infections, represent a great challenge to human health with limited therapeutic options.
Vitor Won-Held Rabelo   +10 more
doaj   +1 more source

In Vitro Antileishmanial Activity and GC-MS Analysis of Whole Plant Hexane Fraction of Achillea wilhelmsii (WHFAW)

open access: yesJournal of Chemistry, 2019
In this study, GC-MS analysis has shown that whole plant hexane fraction of Achillea wilhelmsii (WHFAW) consists of 66 compounds which exhibited antileishmanial activity.
Jahangir Khan Achakzai   +11 more
doaj   +1 more source

Antileishmanial and Antitoxoplasmal Activities of 1,4-dihydropyridines

open access: yesACS Omega
Abstract: We have synthesized 24 1,4-dihydropyridine compounds (1,4-DHPs) with different substituents at the aromatic ring by microwave-assisted one-pot Hantzsch multicomponent reac-tion and evaluated their in vitro activities against Toxoplasma gondii and Leishmania major.
Thaís Oliveira   +9 more
openaire   +3 more sources

Evaluation of Antileishmanial and Antibacterial Activity of Bioconjugate Guanidine–Temporin

open access: yesPharmaceuticals
Background: Peptides are promising tools in medicine for viral, bacterial, and parasitic infections. MAP1 and MAP2 are peptides with antimicrobial activity.
Gabriel Antunes Santoro   +12 more
doaj   +1 more source

Cross-Species Hepatic Metabolism of the Antileishmanial Chalcone NAT22 Generates Metabolites with Predicted Enhanced Affinity for the Parasite Target cTXNPx. [PDF]

open access: yesPharmaceutics
Barreto ARR   +11 more
europepmc   +1 more source

Harnessing nature: a systematic exploration of <i>in vitro</i> antileishmanial and antihuman African trypanosomal properties in traditional medicinal plants and their active principles. [PDF]

open access: yesPharm Biol
Ahmed QU   +10 more
europepmc   +1 more source

Machine Learning-Based QSAR Models for Discovery of Inhibitors Targeting <i>Leishmania infantum</i> Amastigotes. [PDF]

open access: yesPharmaceuticals (Basel)
Flores-Balmaseda N   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy